# Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

> **NCT01074918** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Pre-hypertension
- Hypertension

## Interventions

- **DRUG:** Potassium, Magnesium, Citrate
- **DRUG:** Potassium Chloride

## Key facts

- **NCT ID:** NCT01074918
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** none enrolled per PI
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074918, "Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01074918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*